                         SEQUENCE LISTING

<110>  Oxurion N.V.
 
<120>  TREATMENT OF CORONAVIRAL DISEASE

<130>  PAT2546988EP00

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Bicyclic Peptide

<400>  1

Ser Phe Pro Tyr Arg 
1               5   


<210>  2
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Bicyclic Peptide


<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa represents azetidine carboxylic acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  Xaa represents homo-arginine

<400>  2

Cys Ser Phe Xaa Tyr Xaa Cys Val Tyr Tyr Pro Asp Ile Cys 
1               5                   10                  


<210>  3
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Bicyclic Peptide


<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Xaa represents azetidine carboxylic acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  Xaa represents homo-arginine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Xaa represents Ala(wCH2NH) wherein the carbonyl of the Ala is 
       reduced to methylene

<400>  3

Cys Ser Phe Xaa Tyr Xaa Cys Xaa His Gln Asp Leu Cys 
1               5                   10              


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Bicyclic Peptide


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa represents azetidine carboxylic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Xaa represents homo-arginine

<400>  4

Ser Phe Xaa Tyr Xaa 
1               5   


<210>  5
<211>  58
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Kunitz domain peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(11)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(29)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (31)..(32)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (34)..(35)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (39)..(50)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (52)..(54)
<223>  Xaa can be any naturally occuring amino acid

<220>
<221>  MISC_FEATURE
<222>  (56)..(58)
<223>  Xaa can be any naturally occuring amino acid

<400>  5

Xaa Xaa Xaa Xaa Cys Xaa Xaa Xaa Xaa Xaa Xaa Gly Xaa Cys Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Xaa Xaa 
            20                  25                  30          


Pro Xaa Xaa Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Cys Xaa Xaa Xaa Cys Xaa Xaa Xaa 
    50                  55              


<210>  6
<211>  60
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ecallantide

<400>  6

Glu Ala Met His Ser Phe Cys Ala Phe Lys Ala Asp Asp Gly Pro Cys 
1               5                   10                  15      


Arg Ala Ala His Pro Arg Trp Phe Phe Asn Ile Phe Thr Arg Gln Cys 
            20                  25                  30          


Glu Glu Phe Ile Tyr Gly Gly Cys Glu Gly Asn Gln Asn Arg Phe Glu 
        35                  40                  45              


Ser Leu Glu Glu Cys Lys Lys Met Cys Thr Arg Asp 
    50                  55                  60  


